Accéder au contenu
Merck

Duodenal SP-like immunoreactivity is decreased in experimentally-induced duodenal ulcers.

Neuroscience letters (1990-05-04)
S Evangelista, D Renzi, P Mantellini, C Surrenti, A Meli
RÉSUMÉ

Substance P-like immunoreactivity (SP-li) is decreased in duodenal samples of animals treated with a single dose of an ulcerogen such as dulcerozine, mepirizole or cysteamine. Unlike dulcerozine- or mepirizole-induced ulcers the degree of cysteamine-induced duodenal lesions is inversely correlated with the levels of duodenal SP-li. A significant decrease in duodenal SP-li was observed at 24 h, but not at 6 h after a single oral dose of cysteamine. These findings show that endogenous SP may play an important local role in duodenal ulcerogenesis.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Supelco
Mepirizole, analytical standard